Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot O14639 (ABLM1_HUMAN)

Last modified December 16, 2008. Version 78. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Actin-binding LIM protein 1
Alternative name(s):
    Actin-binding LIM protein family member 1
      Short name=abLIM-1
    Actin-binding double zinc finger protein
    LIMAB1
    Limatin
Gene names
Name: ABLIM1
Synonyms: ABLIM, KIAA0059, LIMAB1
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length778 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

May act as scaffold protein By similarity. May play a role in the development of the retina. Has been suggested to play a role in axon guidance.

Subunit structure

Binds F-actin. Interacts with ABRA. Ref.7

Subcellular location

CytoplasmBy similarity. CytoplasmcytoskeletonBy similarity. Note= Associated with the cytoskeleton By similarity.

Tissue specificity

Detected in liver, heart, skeletal muscle, brain and retina, where it is concentrated in the inner segment and in the outer plexiform layers. Ref.1

Post-translational modification

Phosphorylated upon DNA damage, probably by ATM or ATR. Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15

Sequence similarities

Contains 1 HP (headpiece) domain.

Contains 4 LIM zinc-binding domains.

Binary interactions

With

Entry

#Exp.

IntAct

Notes

LDOC1O957511EBI-487024,EBI-740738

Alternative products

This entry describes 4 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: O14639-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: O14639-2)

The sequence of this isoform differs from the canonical sequence as follows:
     1-81: MPAFLGLKCL...GRVCNSVDPF → MLMTLEMTELTDPHHTMGDYK
Isoform 3 (identifier: O14639-3)

The sequence of this isoform differs from the canonical sequence as follows:
     1-316: Missing.
     480-514: Missing.
Isoform 4 (identifier: O14639-4)

The sequence of this isoform differs from the canonical sequence as follows:
     1-316: Missing.
     348-373: Missing.
     480-514: Missing.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 778778Actin-binding LIM protein 1
PRO_0000075697

Regions

Domain97 – 15660LIM zinc-binding 1
Domain156 – 21661LIM zinc-binding 2
Domain224 – 28360LIM zinc-binding 3
Domain283 – 34361LIM zinc-binding 4
Domain710 – 77869HP
Coiled coil590 – 61425 Potential

Amino acid modifications

Modified residue2161Phosphoserine By similarity
Modified residue3531Phosphoserine By similarity
Modified residue3571Phosphotyrosine Ref.8
Modified residue3671Phosphoserine By similarity
Modified residue3731Phosphotyrosine Ref.8
Modified residue3961Phosphotyrosine Ref.10
Modified residue4061Phosphotyrosine Ref.10
Modified residue4101Phosphotyrosine Ref.10
Modified residue4311Phosphoserine Ref.9 Ref.14 Ref.15
Modified residue4351Phosphoserine Ref.8 Ref.15
Modified residue4391Phosphotyrosine Ref.8
Modified residue4501Phosphoserine By similarity
Modified residue4521Phosphoserine Ref.9 Ref.13
Modified residue4551Phosphoserine Ref.15
Modified residue4581Phosphoserine Ref.13 Ref.15
Modified residue4611Phosphotyrosine Ref.8 Ref.11
Modified residue4731Phosphoserine Ref.12
Modified residue5871Phosphoserine Ref.15
Modified residue6401Phosphoserine Ref.15
Modified residue6551Phosphoserine Ref.9 Ref.15
Modified residue7061Phosphoserine Ref.9 Ref.15

Natural variations

Alternative sequence1 – 316316Missing in isoform 3 and isoform 4.
VSP_012099
Alternative sequence1 – 8181MPAFL…SVDPF → MLMTLEMTELTDPHHTMGDY K in isoform 2.
VSP_012100
Alternative sequence348 – 37326Missing in isoform 4.
VSP_012101
Alternative sequence480 – 51435Missing in isoform 3 and isoform 4.
VSP_012102
Natural variant4341P → T: dbSNP rs11593544.
VAR_050141
Natural variant6371R → G: dbSNP rs7091419.
VAR_050142

Experimental info

Sequence conflict4991R → L in AAC51676. Ref.1
Sequence conflict5321A → R in AAC51676. Ref.1
Sequence conflict5631K → E in BAA06681. Ref.2
Sequence conflict5781V → I in BAA06681. Ref.2

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified September 23, 2008. Version 3.
Checksum: EBC2F14BE558752B

FASTA77887,688
        10         20         30         40         50         60 
MPAFLGLKCL GKLCSSEKSK VTSSERTSAR GSNRKRLIVE DRRVSGTSFT AHRRATITHL 

        70         80         90        100        110        120 
LYLCPKDYCP RGRVCNSVDP FVAHPQDPHH PSEKPVIHCH KCGEPCKGEV LRVQTKHFHI 

       130        140        150        160        170        180 
KCFTCKVCGC DLAQGGFFIK NGEYLCTLDY QRMYGTRCHG CGEFVEGEVV TALGKTYHPN 

       190        200        210        220        230        240 
CFACTICKRP FPPGDRVTFN GRDCLCQLCA QPMSSSPKET TFSSNCAGCG RDIKNGQALL 

       250        260        270        280        290        300 
ALDKQWHLGC FKCKSCGKVL TGEYISKDGA PYCEKDYQGL FGVKCEACHQ FITGKVLEAG 

       310        320        330        340        350        360 
DKHYHPSCAR CSRCNQMFTE GEEMYLQGST VWHPDCKQST KTEEKLRPTR TSSESIYSRP 

       370        380        390        400        410        420 
GSSIPGSPGH TIYAKVDNEI LDYKDLAAIP KVKAIYDIER PDLITYEPFY TSGYDDKQER 

       430        440        450        460        470        480 
QSLGESPRTL SPTPSAEGYQ DVRDRMIHRS TSQGSINSPV YSRHSYTPTT SRSPQHFHRP 

       490        500        510        520        530        540 
GNEPSSGRNS PLPYRPDSRP LTPTYAQAPK HFHVPDQGIN IYRKPPIYKQ HAALAAQSKS 

       550        560        570        580        590        600 
SEDIIKFSKF PAAQAPDPSE TPKIETDHWP GPPSFAVVGP DMKRRSSGRE EDDEELLRRR 

       610        620        630        640        650        660 
QLQEEQLMKL NSGLGQLILK EEMEKESRER SSLLASRYDS PINSASHIPS SKTASLPGYG 

       670        680        690        700        710        720 
RNGLHRPVST DFAQYNSYGD VSGGVRDYQT LPDGHMPAMR MDRGVSMPNM LEPKIFPYEM 

       730        740        750        760        770 
LMVTNRGRNK ILREVDRTRL ERHLAPEVFR EIFGMSIQEF DRLPLWRRND MKKKAKLF 

« Hide

Isoform 2.

Checksum: A9CAEEBA95BDF15E
Show »

71881,121
Isoform 3.

Checksum: 1721FB3EC1D99994
Show »

42748,804
Isoform 4.

Checksum: 0B2AC94C24A5D72F
Show »

40146,087

References

« Hide 'large scale' references
[1]"Molecular characterization of abLIM, a novel actin-binding and double zinc finger protein."
Roof D.J., Hayes A., Adamian M., Chishti A.H., Li T.
J. Cell Biol. 138:575-588(1997) [PubMed: 9245787] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ALTERNATIVE SPLICING, TISSUE SPECIFICITY.
Tissue: Retina.
[2]"Prediction of the coding sequences of unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of cDNA clones from human cell line KG-1."
Nomura N., Nagase T., Miyajima N., Sazuka T., Tanaka A., Sato S., Seki N., Kawarabayasi Y., Ishikawa K., Tabata S.
DNA Res. 1:223-229(1994) [PubMed: 7584044] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
Tissue: Bone marrow.
[3]"Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones."
Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.
DNA Res. 9:99-106(2002) [PubMed: 12168954] [Abstract]
Cited for: SEQUENCE REVISION.
[4]The German cDNA consortium
Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
Tissue: Retina.
[5]"The DNA sequence and comparative analysis of human chromosome 10."
Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J. expand/collapse author list , Bird C.P., Ainscough R., Almeida J.P., Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.
Nature 429:375-381(2004) [PubMed: 15164054] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[6]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
Tissue: Kidney.
[7]"Two novel members of the ABLIM protein family, ABLIM-2 and -3, associate with STARS and directly bind F-actin."
Barrientos T., Frank D., Kuwahara K., Bezprozvannaya S., Pipes G.C.T., Bassel-Duby R., Richardson J.A., Katus H.A., Olson E.N., Frey N.
J. Biol. Chem. 282:8393-8403(2007) [PubMed: 17194709] [Abstract]
Cited for: INTERACTION WITH ABRA.
[8]"Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry."
Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., Peters E.C.
Anal. Chem. 76:2763-2772(2004) [PubMed: 15144186] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-357; TYR-373; SER-435; TYR-439 AND TYR-461, MASS SPECTROMETRY.
Tissue: T-cell.
[9]"Large-scale characterization of HeLa cell nuclear phosphoproteins."
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431; SER-452; SER-655 AND SER-706, MASS SPECTROMETRY.
Tissue: Epithelium.
[10]"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells."
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J.
Nat. Biotechnol. 23:94-101(2005) [PubMed: 15592455] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-396; TYR-406 AND TYR-410, MASS SPECTROMETRY.
[11]"Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry."
Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J., Bodenmiller B., Watts J.D., Hood L., Aebersold R.
Nat. Methods 2:591-598(2005) [PubMed: 16094384] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-461, MASS SPECTROMETRY.
Tissue: T-cell.
[12]"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.
Cell 127:635-648(2006) [PubMed: 17081983] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-473, MASS SPECTROMETRY.
Tissue: Epithelium.
[13]"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage."
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.
Science 316:1160-1166(2007) [PubMed: 17525332] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-452 AND SER-458, MASS SPECTROMETRY.
[14]"Phosphoproteome of resting human platelets."
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A.
J. Proteome Res. 7:526-534(2008) [PubMed: 18088087] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431, MASS SPECTROMETRY.
Tissue: Platelet.
[15]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431; SER-435; SER-455; SER-458; SER-587; SER-640; SER-655 AND SER-706, MASS SPECTROMETRY.